Library

• Bladder cancer 2024
• Overactive bladder syndrome
• Duplex Congenital Malformations of the UT
• Bipolar enucleation of the prostate
• Duplex Congenital Malformations of the UT
• Nocturia QR Code
• Fatigue in prostate cancer patients – HCP Guide
• What is cancer?
• Kidney stones plus QR Code
• Erectile dysfunction
• BPE QR Code
• ADT-related CVD QR Code
• PSA Testing QR Code
• Orchidectomy QR Code
• Hormone therapy QR Code
• Prostate Cancer QR Code
• Urinary Infections QR Code
• Urinary Incontinence QR Code
• CPP Sept 2022
• Chronic Pelvic Pain (CPP)
• Urinary Infections
• Overactive Bladder 2022
• Cancer at Work – Tips for employers supporting employees with cancer
• Cancer at Work – Tips for employees diagnosed with cancer
• Flyer ADT Online Educational Class
• EAU21 Patient Poster Session – Key messages
• Roundtable Discussion EAU21
• ECL Rehabilitation Atlas 2021
• Chronic Pelvic Pain Syndrome
• Hormone Therapy
• EAU21 Patient Poster Session – What have we learned
• EAU22 Rules for abstract submission PI
• IKCC Report: The impact of COVID-19 on the kidney cancer community
• Orchidectomy
• EAU21 Roundtable – The Road to Succesful Intervention – Patient Information session
• EAU21 Patient Poster presentations – Patient Information session Friday 9 July 2021
• EAU21 Kidney cancer Patient Information session – 9 July 2021
• EAU21 Functional Urology Patient Information session – 9 July 2021
• Prostate Cancer
• Hormone Therapy and the Risk of Cardiovascular Disease in Patients with Prostate Cancer
• Early Detection HVP – Hogenhout et al. 2020
• Study Non-metastatic Castration-Resistant Prostate
• Patient Summary Darolutamide and survival in nonmetastatic castration-resistant prostate cancer – A Patient perspective of the ARAMIS trial
• EAU21 Treatment sequencing in metastatic prostate cancer
• EAU21 Treatment for metastatic hormone-sensitive prostate cancer
• EAU21 Metastatic prostate cancer: Systemic treatments and options of loc treatment in oligometastatic disease
• EAU21 Metastatic prostate cancer – Poster Session 29
• EAU21 Guideline Session II: Prostate cancer – cN+ in newly diagnosed patients
• EAU21 Game changing session 5
• EAU21 Urinary biomarkers: Are we there yet?
• EAU21 Telemedicine in urology
• EAU21 Ready for take-off: Molecular markers for clin management of urological malignancies
• EAU21 History of urology at a glance
• EAU21 Germline genetic testing and clin cons for patients and relative in onco-urology
• EAU21 Controversies in onco-urology
• EAU21 Clinical trials Poster Session 30
• EAU21 Best of EAU21 poster abstracts
• EAU21 Immunotherapy in urothelial cancer
• EAU21 Renal tumours – Locally advanced and metastatic disease
• EAU21 Nephron-sparing treatment in localised kidney cancer
• EAU21 Localised renal tumour diagnosis and prognosis in the digitalised era
• EAU21 A tale of three kidneys – Complex and salvage robotic kidney surgery
• EAU21 Prostate Cancer PI Session
• World Continence Week 2021 – WFIPP Webinar Programme
• EAU21 Functional Urology PI Session
• EAU21 Life After Cancer Treatment PI Session
• EAU21 PIONEER prostate cancer platform
• EAU21 How machine learning is transforming diagnostics
• EAU21 Guidelines Poster Session 11
• EAU21 Controversies in Bladder Cancer 2021: Rapid-fire debates
• EAU21 Advanced bladder cancer in 2021: Going forward?
• EAU21 Kidney cancer – Patient Information Session
• EAU21 Bladder cancer – Patient Information Session
• Prostate Cancer Patient Guide (Prostate Cancer Foundation)
• EAU21 Plenary session 04 – Renal cancer: from localised to metastatic disease
• EAU21 Poster Session 19 – Liquid biopsies, biomarkers and novel therapies in renal tumours
• EAU21 Poster Session 07 – Patient engagement
• EAU21 Roundtable The Road to successful interventions
• EAU21 Patient poster presentations
• Cost and value of surgery for kidney cancer patients in the USA
• Joint Letter on COVID-19 and Cancer
• EU Beating Cancer Plan
• EAU Guidelines on Renal Cell Carcinoma
• MAC Guide PCa
• How to manage cancer at work – ECL Cancer at Work Handbook
• EMA medical terms simplifier
• ECPC personalised medicine booklet
• Patient Summary BCa Newsletter March 2021
• Study Mentall Illness and Bladder Cancer Patients
• Patient Summary GO BCa Newsletter March 2021
• Patient Summary PCa Newsletter February 2021
• Full text Living with Prostate Cancer and ADT
• ADT-programme endorsement by Mrs. Louise Fleure
• Patient Summary GO RCC Newsletter January 2021
• Full text EAU Guidelines Update on RCC – Nivolumab plus Cabozantinib
• Patient Summary RCC Newsletter January 2021
• Full text Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer
• Full text Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
• Patient Summary BCa Newsletter December 2020
• Patient Summary PCa Newsletter November 2020